7MM Gout Opportunity Assessment and Forecasts 2022-2024 & 2024-2032: Epidemiology, Current Treatment Options, Unmet Needs and Opportunities, Pipeline Assessment, R&D Strategies, Outlook
January 17, 2025 06:17 ET
|
Research and Markets
Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Gout: Opportunity Assessment and Forecast - Update" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM (US, 5EU,...
Engineered Multispecific Antibodies Innovation Research Report 2024: Patent Trends Show a Noticeable Surge in 2023 with Regeneron, Roche, and Amgen Emerging as the Top Patent Filers
January 17, 2025 04:57 ET
|
Research and Markets
Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Innovation Insights: Engineered Multispecific antibodies" report has been added to ResearchAndMarkets.com's offering.Engineered multispecific...
Systemic Lupus Erythematosus (SLE) Market Forecast at $6.19 Billion by 2034: In-Depth Analysis by Drug Class, Route of Administration, Distribution Channel and Region
January 16, 2025 04:02 ET
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Systemic Lupus Erythematosus Market by Drug Class, Route of Administration, Distribution Channel, and Region" report has been added to ...
Aspirin Industry Eyes $2.1 Billion Valuation by 2030: Tablets Will Continue to Dominate, Maintaining Around 60-65% Market Share
January 13, 2025 07:59 ET
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type" report has been...
Immunotoxins Market Trends and Regional Business Opportunities, 2024-2034: Diphtheria Toxin-Based Immunotoxins Lead Revenue, Pseudomonas Exotoxins Show Rapid Growth Potential
January 09, 2025 04:52 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Immunotoxins Market by Product, by Application, by End-User, and by Region" report has been added to ResearchAndMarkets.com's offering. This...
2024 Research Report: Global Celiac Disease Treatment Market Projected to Reach $2.24 Billion by 2035 with a CAGR of 11.84%
January 08, 2025 11:47 ET
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Celiac Disease Treatment Market by Treatment, by Route of Administration, by Distribution Channel, and By Region" report has been added to ...
Antibodies Contract Manufacturing Market Research 2024 with Global Long-term Forecasts to 2035: Expansion of Emerging Markets, Personalized Medicine, Therapeutic Antibodies Demand Fueling Growth
January 08, 2025 11:42 ET
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Antibodies Contract Manufacturing Market by Product, by Source, by End-User, and By Region" report has been added to ResearchAndMarkets.com's...
Myositis Therapeutics Market Report 2024: Comprehensive Insights about 18+ Companies and 20+ Pipeline Drugs
December 18, 2024 09:37 ET
|
Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Myositis - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Forecast to 2034 - Immunovant Advances FcRn Inhibitor Pipeline with Promising Results and FDA Green Light for Pivotal Trial
December 11, 2024 06:25 ET
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's...
Graves' Disease Pipeline Drug Research Report 2024 Featuring Viridian Therapeutics, Immunovant Sciences, Apitope International, Sling Therapeutics, and Novartis
December 02, 2024 05:23 ET
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Graves' Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report outlays comprehensive insights...